A NON-CONTROLLED PROSPECTIVE COHORT STUDY OF THE USE OF ASKINA® CALGITROL® PASTE + STANDARD OF CARE ON MILDLY INFECTED, NON-ISCHAEMIC DIABETIC FOOT ULCERS
The purpose of this study is to assess the efficacy of Askina® Calgitrol® Paste in reducing local infection in subjects treated for mildly infected Diabetic Foot Ulcers (DFU) with Askina® Calgitrol® Paste.
Indication: Diabetic Foot Ulcer (DFU)
Modality: medical device
Target: Askina Calgitrol paste
Sponsor: BBraun Medical SAS
Source URL: ClinicalTrials.gov
Source updated: Jul 31, 2015
Ingested: Jun 08, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Askina Calgitrol paste
View original source fields
Condition raw: Diabetic Foot Ulcer (DFU)
Condition normalized: Diabetic Foot Ulcer (DFU)
Modality raw: medical device
Modality normalized: medical device
Target raw: Askina Calgitrol paste
Target normalized: Askina Calgitrol paste